Nyxoah (NYXH) Total Non-Current Liabilities (2020 - 2026)
Nyxoah (NYXH) recorded quarterly Total Non-Current Liabilities of $24.2 million in Q1 2026, up 1.99% quarter-over-quarter from $23.7 million in Q4 2025, and up 4.15% on a YoY basis from $23.2 million in Q1 2025.
Nyxoah (NYXH) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Nyxoah's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $24.2 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 4.15% year-over-year to $24.2 million; the TTM figure through Mar 2026 stood at $24.2 million (up 4.15% YoY), while the FY2025 annual figure was $23.7 million, down 6.0% from the prior year.
- Total Non-Current Liabilities was $24.2 million for Q1 2026 at Nyxoah, up from $23.7 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $11.1 billion in Q3 2022 to a low of -$484.0 million in Q3 2025.
- Historically, Total Non-Current Liabilities has averaged $678.7 million across 5 years, with a median of $18.1 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities surged 130.68% in 2023, then slumped 2081.94% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $11.1 million in 2022, then increased by 13.81% to $12.6 million in 2023, then soared by 100.66% to $25.2 million in 2024, then decreased by 6.0% to $23.7 million in 2025, then increased by 1.99% to $24.2 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $24.2 million (Q1 2026), $23.7 million (Q4 2025), and -$484.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | 24.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.20 Mn |
| Dec 31, 2025 | 23.73 Mn |
| Sep 30, 2025 | -483.99 Mn |
| Jun 30, 2025 | 25.05 Mn |
| Mar 31, 2025 | 23.23 Mn |
| Dec 31, 2024 | 25.24 Mn |
| Sep 30, 2024 | 24.42 Mn |
| Jun 30, 2024 | 12.60 Mn |
| Mar 31, 2024 | 12.87 Mn |
| Dec 31, 2023 | 12.58 Mn |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 12.63 Mn |
| Mar 31, 2023 | 27.75 Mn |
| Dec 31, 2022 | 11.05 Mn |
| Sep 30, 2022 | 11.08 Bn |
| Mar 31, 2022 | 12.03 Mn |
| Dec 31, 2021 | 12.17 Mn |
| Jun 30, 2021 | -55.40 Mn |
| Dec 31, 2020 | 12.50 Mn |